{"transactions":[{"id":4619765,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":21373,"kind":"organization","name":"WEXFORD CAPITAL LP","position":1,"cik":"0001048462","reported_name":"WEXFORD CAPITAL LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21374,"kind":"organization","name":"Wexford GP LLC","position":2,"cik":"0001472112","reported_name":"Wexford GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21375,"kind":"person","name":"DAVIDSON CHARLES E","position":3,"cik":"0001001391","reported_name":"DAVIDSON CHARLES E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21376,"kind":"person","name":"JACOBS JOSEPH","position":4,"cik":"0001048485","reported_name":"JACOBS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-09-16T21:05:43.000Z","date":"2026-09-14","kind":"other","planned":false,"acquired":false,"shares":22710,"price":3.95,"value":89704.5,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a sale of certain shares of common stock from the Distributing Entities to an entity controlled by Arthur Amron, a current director of the Issuer and a former employee of Wexford Capital LP (\"Wexford Capital\"), the proceeds of which were distributed to certain underlying investors of the Distributing Entities. No Distributing Entities shall receive any compensation, directly or indirectly, in connection with the transaction described herein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Represents the common stock of the Issuer held by WST."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Wexford Capital may, by reason of its status as (i) sub-advisor of WST, (ii) investment manager of WP11 and (iii) manager of WPIC2, (WPIC2, together with WST and WP11, the \"Wexford Entities\"), be deemed to own beneficially the shares of Common Stock held by the Wexford Entities. Wexford GP may, by reason of its status as General Partner of Wexford Capital, be deemed to own beneficially the shares of Common Stock held by the Wexford Entities. Each of Messrs. Davidson and Jacobs may, by reason of his status as a controlling person of Wexford GP and WP Advisors, be deemed to own beneficially the shares of Common Stock held by the Wexford Entities and WP Advisors."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Each of Wexford Capital, Wexford GP, Davidson and Jacobs shares the power to vote and to dispose of the shares of Common Stock held by the Wexford Entities. Each of Davidson and Jacobs shares the power to vote and to dispose of the shares of Common Stock held by WP Advisors. Each of Wexford Capital, Wexford GP and Messrs. Davidson and Jacobs disclaims beneficial ownership of the shares of Common Stock held by the Wexford Entities and/or WP Advisors, as applicable, and this report shall not be deemed as an admission that they are the beneficial owner of such securities except, in the case of Davidson and Jacobs, to the extent of their respective pecuniary interests therein."}],"balance_after":166667,"source":{"system":"sec-edgar","filing":"0001398344-26-017120","document":"fp0100871-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472112/000139834426017120/fp0100871-1_4.xml","form_type":"4"}},{"id":4619764,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":21373,"kind":"organization","name":"WEXFORD CAPITAL LP","position":1,"cik":"0001048462","reported_name":"WEXFORD CAPITAL LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21374,"kind":"organization","name":"Wexford GP LLC","position":2,"cik":"0001472112","reported_name":"Wexford GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21375,"kind":"person","name":"DAVIDSON CHARLES E","position":3,"cik":"0001001391","reported_name":"DAVIDSON CHARLES E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21376,"kind":"person","name":"JACOBS JOSEPH","position":4,"cik":"0001048485","reported_name":"JACOBS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-09-16T21:05:43.000Z","date":"2026-09-14","kind":"other","planned":false,"acquired":false,"shares":3355111,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an in-kind distribution of certain shares of common stock from Wexford Partners 11, L.P. (\"WP11\"), Wexford 11 Advisors LLC (\"WP Advisors\") and WPIC 2 LLC (\"WPIC2\", and together with WP11 and WP Advisors, the \"Distributing Entities\") that does not involve (i) a purchase or a sale of securities or (ii) any additional consideration."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents the common stock of the Issuer held by the Distributing Entities and Wexford Spectrum Trading Limited (\"WST\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Wexford Capital may, by reason of its status as (i) sub-advisor of WST, (ii) investment manager of WP11 and (iii) manager of WPIC2, (WPIC2, together with WST and WP11, the \"Wexford Entities\"), be deemed to own beneficially the shares of Common Stock held by the Wexford Entities. Wexford GP may, by reason of its status as General Partner of Wexford Capital, be deemed to own beneficially the shares of Common Stock held by the Wexford Entities. Each of Messrs. Davidson and Jacobs may, by reason of his status as a controlling person of Wexford GP and WP Advisors, be deemed to own beneficially the shares of Common Stock held by the Wexford Entities and WP Advisors."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Each of Wexford Capital, Wexford GP, Davidson and Jacobs shares the power to vote and to dispose of the shares of Common Stock held by the Wexford Entities. Each of Davidson and Jacobs shares the power to vote and to dispose of the shares of Common Stock held by WP Advisors. Each of Wexford Capital, Wexford GP and Messrs. Davidson and Jacobs disclaims beneficial ownership of the shares of Common Stock held by the Wexford Entities and/or WP Advisors, as applicable, and this report shall not be deemed as an admission that they are the beneficial owner of such securities except, in the case of Davidson and Jacobs, to the extent of their respective pecuniary interests therein."}],"balance_after":189377,"source":{"system":"sec-edgar","filing":"0001398344-26-017120","document":"fp0100871-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472112/000139834426017120/fp0100871-1_4.xml","form_type":"4"}},{"id":4619724,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":23456,"kind":"person","name":"Amron Arthur H","position":1,"cik":"0001179697","reported_name":"Amron Arthur H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":36460,"kind":"person","name":"Amron Holdings LLC","position":2,"cik":"0002139960","reported_name":"Amron Holdings LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-16T20:59:48.000Z","date":"2026-09-14","kind":"other","planned":false,"acquired":true,"shares":22710,"price":3.95,"value":89704.5,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a sale of certain shares of common stock from the Wexford Entities to Amron Holdings, the proceeds of which were distributed to certain underlying investors of the Wexford Entities. No Wexford Entities shall receive any compensation, directly or indirectly, in connection with the transaction described herein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents the common stock of the Issuer held by Amron Holdings LLC (\"Amron Holdings\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Arthur Amron may, by reason of his status as a controlling person of Amron Holdings, be deemed to own beneficially the securities held by Amron Holdings. Mr. Amron holds the power to vote and to dispose of the securities held by Amron Holdings."}],"balance_after":25546,"source":{"system":"sec-edgar","filing":"0001398344-26-017116","document":"fp0100871-2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2139960/000139834426017116/fp0100871-2_4.xml","form_type":"4"}},{"id":4619723,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":23456,"kind":"person","name":"Amron Arthur H","position":1,"cik":"0001179697","reported_name":"Amron Arthur H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":36460,"kind":"person","name":"Amron Holdings LLC","position":2,"cik":"0002139960","reported_name":"Amron Holdings LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-16T20:59:48.000Z","date":"2026-09-14","kind":"other","planned":false,"acquired":true,"shares":2836,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an in-kind distribution from Wexford Partners 11, L.P. (\"WP11\"), Wexford 11 Advisors LLC (\"WP Advisors\") and WPIC 2 LLC (\"WPIC2\", and together with WP11 and WP Advisors, the \"Wexford Entities\") that does not involve (i) a purchase or a sale of securities or (ii) any additional consideration."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents the common stock of the Issuer held by Amron Holdings LLC (\"Amron Holdings\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Arthur Amron may, by reason of his status as a controlling person of Amron Holdings, be deemed to own beneficially the securities held by Amron Holdings. Mr. Amron holds the power to vote and to dispose of the securities held by Amron Holdings."}],"balance_after":2836,"source":{"system":"sec-edgar","filing":"0001398344-26-017116","document":"fp0100871-2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2139960/000139834426017116/fp0100871-2_4.xml","form_type":"4"}},{"id":4619722,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":23456,"kind":"person","name":"Amron Arthur H","position":1,"cik":"0001179697","reported_name":"Amron Arthur H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":36460,"kind":"person","name":"Amron Holdings LLC","position":2,"cik":"0002139960","reported_name":"Amron Holdings LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-16T20:59:48.000Z","date":"2026-09-14","kind":"other","planned":false,"acquired":true,"shares":17749,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an in-kind distribution from Wexford Partners 11, L.P. (\"WP11\"), Wexford 11 Advisors LLC (\"WP Advisors\") and WPIC 2 LLC (\"WPIC2\", and together with WP11 and WP Advisors, the \"Wexford Entities\") that does not involve (i) a purchase or a sale of securities or (ii) any additional consideration."}],"balance_after":158623,"source":{"system":"sec-edgar","filing":"0001398344-26-017116","document":"fp0100871-2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2139960/000139834426017116/fp0100871-2_4.xml","form_type":"4"}},{"id":680454,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":21373,"kind":"organization","name":"WEXFORD CAPITAL LP","position":1,"cik":"0001048462","reported_name":"WEXFORD CAPITAL LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21374,"kind":"organization","name":"Wexford GP LLC","position":2,"cik":"0001472112","reported_name":"Wexford GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21375,"kind":"person","name":"DAVIDSON CHARLES E","position":3,"cik":"0001001391","reported_name":"DAVIDSON CHARLES E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21376,"kind":"person","name":"JACOBS JOSEPH","position":4,"cik":"0001048485","reported_name":"JACOBS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-20T20:14:37.000Z","date":"2026-08-18","kind":"exercise","planned":false,"acquired":false,"shares":3765,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third of the options vested immediately upon the grant date of August 24, 2016. The remainder of the options vested in equal annual installments on each of the first and second anniversaries of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes stock options granted to Wexford Capital as reported in Form 4s previously filed by Arthur Amron, a current director of the Issuer and a former employee of Wexford Capital."}],"balance_after":36198,"derivative":{"exercise_price":3.6,"expiration_date":"2026-08-24","underlying":"Common Stock","underlying_shares":3765},"source":{"system":"sec-edgar","filing":"0001398344-26-015086","document":"fp0100570-1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001391/000139834426015086/fp0100570-1_4.xml","form_type":"4"}},{"id":680453,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":21373,"kind":"organization","name":"WEXFORD CAPITAL LP","position":1,"cik":"0001048462","reported_name":"WEXFORD CAPITAL LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21374,"kind":"organization","name":"Wexford GP LLC","position":2,"cik":"0001472112","reported_name":"Wexford GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21375,"kind":"person","name":"DAVIDSON CHARLES E","position":3,"cik":"0001001391","reported_name":"DAVIDSON CHARLES E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21376,"kind":"person","name":"JACOBS JOSEPH","position":4,"cik":"0001048485","reported_name":"JACOBS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-20T20:14:37.000Z","date":"2026-08-18","kind":"exercise","planned":false,"acquired":true,"shares":812,"price":3.6,"value":2923.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the net number of shares of common stock issued upon the cashless exercise of stock options to purchase 3,765 shares, after a portion of the option shares was withheld to satisfy the exercise price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Includes shares of common stock granted to Wexford Capital LP (\"Wexford Capital\") as reported in Form 4s previously filed by Arthur Amron, a current director of the Issuer and a former employee of Wexford Capital."}],"balance_after":56872,"source":{"system":"sec-edgar","filing":"0001398344-26-015086","document":"fp0100570-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001391/000139834426015086/fp0100570-1_4.xml","form_type":"4"}},{"id":687146,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":23456,"kind":"person","name":"Amron Arthur H","position":1,"cik":"0001179697","reported_name":"Amron Arthur H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-14T20:05:33.000Z","date":"2026-08-12","kind":"grant","planned":false,"acquired":true,"shares":2418,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued to reporting person in lieu of cash fees for board service."}],"balance_after":140874,"source":{"system":"sec-edgar","filing":"0000914190-26-000110","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1179697/000091419026000110/form4.xml","form_type":"4"}},{"id":740356,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":23456,"kind":"person","name":"Amron Arthur H","position":1,"cik":"0001179697","reported_name":"Amron Arthur H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T21:57:30.000Z","date":"2026-05-11","kind":"grant","planned":false,"acquired":true,"shares":3574,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued to reporting person in lieu of cash fees for board service."}],"balance_after":138456,"source":{"system":"sec-edgar","filing":"0000914190-26-000098","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1179697/000091419026000098/form4.xml","form_type":"4"}},{"id":828146,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":56038,"kind":"person","name":"Banks Robert R. Jr.","position":1,"cik":"0001977237","reported_name":"Banks Robert R. Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-25T20:54:04.000Z","date":"2026-03-23","kind":"exercise","planned":false,"acquired":false,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 89,291 shares vest on 5/5/24 and options to purchase 267,874 shares vest quarterly in 12 equal amounts commencing on 8/5/24."}],"balance_after":237165,"derivative":{"exercise_price":1.44,"expiration_date":"2033-05-05","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0000914190-26-000053","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000091419026000053/form4.xml","form_type":"4"}},{"id":828145,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":56038,"kind":"person","name":"Banks Robert R. Jr.","position":1,"cik":"0001977237","reported_name":"Banks Robert R. Jr.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-25T20:54:04.000Z","date":"2026-03-23","kind":"exercise","planned":false,"acquired":true,"shares":120000,"price":1.44,"value":172800.0,"ownership":{"direct":true},"balance_after":190000,"source":{"system":"sec-edgar","filing":"0000914190-26-000053","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000091419026000053/form4.xml","form_type":"4"}},{"id":828229,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":56056,"kind":"person","name":"Krandel Judy","position":1,"cik":"0001668351","reported_name":"Krandel Judy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-25T20:53:39.000Z","date":"2026-03-23","kind":"exercise","planned":false,"acquired":false,"shares":68861,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 30,631 shares vest on 11/1/2024 and options to purchase the remaining 91,893 shares vest quarterly in 12 equal amounts commencing on 2/1/2025."}],"balance_after":53663,"derivative":{"exercise_price":1.71,"expiration_date":"2033-11-01","underlying":"Common Stock","underlying_shares":68861},"source":{"system":"sec-edgar","filing":"0000914190-26-000052","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668351/000091419026000052/form4.xml","form_type":"4"}},{"id":828228,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":56056,"kind":"person","name":"Krandel Judy","position":1,"cik":"0001668351","reported_name":"Krandel Judy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-25T20:53:39.000Z","date":"2026-03-23","kind":"exercise","planned":false,"acquired":true,"shares":68861,"price":1.71,"value":117752.31,"ownership":{"direct":true},"balance_after":68861,"source":{"system":"sec-edgar","filing":"0000914190-26-000052","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668351/000091419026000052/form4.xml","form_type":"4"}},{"id":835478,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":23456,"kind":"person","name":"Amron Arthur H","position":1,"cik":"0001179697","reported_name":"Amron Arthur H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-18T21:23:08.000Z","date":"2026-03-16","kind":"grant","planned":false,"acquired":true,"shares":3610,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued to reporting person in lieu of cash fees for board service."}],"balance_after":134882,"source":{"system":"sec-edgar","filing":"0000914190-26-000042","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1179697/000091419026000042/form4.xml","form_type":"4"}},{"id":834988,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":56056,"kind":"person","name":"Krandel Judy","position":1,"cik":"0001668351","reported_name":"Krandel Judy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-18T20:17:19.000Z","date":"2026-03-16","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options to purchase 1,000 shares vest on 3/16/2027 and options to purchase the remaining 3,000 shares vest quarterly in 12 equal amounts commencing on 6/16/2027."}],"balance_after":4000,"derivative":{"exercise_price":2.92,"expiration_date":"2036-03-16","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0000914190-26-000041","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668351/000091419026000041/form4.xml","form_type":"4"}},{"id":999999,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":73210,"kind":"person","name":"Spandow Oliver J.","position":1,"cik":"0001749836","reported_name":"Spandow Oliver J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-13T21:59:35.000Z","date":"2025-11-10","kind":"grant","planned":false,"acquired":true,"shares":8036,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":122881,"source":{"system":"sec-edgar","filing":"0000914190-25-000040","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000091419025000040/form4.xml","form_type":"4"}},{"id":1000624,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":23456,"kind":"person","name":"Amron Arthur H","position":1,"cik":"0001179697","reported_name":"Amron Arthur H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-13T21:58:35.000Z","date":"2025-11-10","kind":"grant","planned":false,"acquired":true,"shares":5391,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":131272,"source":{"system":"sec-edgar","filing":"0000914190-25-000039","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1179697/000091419025000039/form4.xml","form_type":"4"}},{"id":1000615,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":73249,"kind":"person","name":"Nettis Lisa Marie","position":1,"cik":"0002076008","reported_name":"Nettis Lisa Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-13T17:00:38.000Z","date":"2025-11-10","kind":"grant","planned":false,"acquired":true,"shares":1622,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1622,"source":{"system":"sec-edgar","filing":"0000914190-25-000041","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2076008/000091419025000041/form4.xml","form_type":"4"}},{"id":1068010,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":73249,"kind":"person","name":"Nettis Lisa Marie","position":1,"cik":"0002076008","reported_name":"Nettis Lisa Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-08-13T16:09:44.000Z","date":"2025-08-11","kind":"grant","planned":false,"acquired":true,"shares":13229,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 4,410 shares on each of 6/16/25 and 6/16/26 and 4,409 options vest on 6/16/27."}],"balance_after":13229,"derivative":{"exercise_price":4.49,"expiration_date":"2035-08-11","underlying":"Common Stock","underlying_shares":13229},"source":{"system":"sec-edgar","filing":"0001062993-25-014297","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2076008/000106299325014297/form4.xml","form_type":"4"}},{"id":1187964,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":56056,"kind":"person","name":"Krandel Judy","position":1,"cik":"0001668351","reported_name":"Krandel Judy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-31T20:11:30.000Z","date":"2025-03-27","kind":"grant","planned":false,"acquired":true,"shares":54359,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to purchase 13,589 shares vest on 3/27/2026 and options to purchase the remaining 40,770 shares vest quarterly in 12 equal amounts commencing on 6/27/2026."}],"balance_after":54359,"derivative":{"exercise_price":1.68,"expiration_date":"2035-03-27","underlying":"Common Stock","underlying_shares":54359},"source":{"system":"sec-edgar","filing":"0001062993-25-006570","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668351/000106299325006570/form4.xml","form_type":"4"}},{"id":1315708,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":23456,"kind":"person","name":"Amron Arthur H","position":1,"cik":"0001179697","reported_name":"Amron Arthur H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-03T23:13:00.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":7050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents options granted to the reporting person for his service on the Company's Board of Directors for 2024.  This option vests as to 2,350 shares on each of 1/1/25, 1/1/26 and 1/1/27."}],"balance_after":7050,"derivative":{"exercise_price":1.47,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":7050},"source":{"system":"sec-edgar","filing":"0001062993-25-000264","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1179697/000106299325000264/form4.xml","form_type":"4"}},{"id":1315707,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":23456,"kind":"person","name":"Amron Arthur H","position":1,"cik":"0001179697","reported_name":"Amron Arthur H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-03T23:13:00.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":22418,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":125881,"source":{"system":"sec-edgar","filing":"0001062993-25-000264","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1179697/000106299325000264/form4.xml","form_type":"4"}},{"id":1314015,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":58047,"kind":"person","name":"Lask Alisa","position":1,"cik":"0001767593","reported_name":"Lask Alisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-03T22:08:03.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":7050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents options granted to the reporting person for her service on the Company's Board of Directors for 2024. This option vests as to 2,350 shares  on each of 1/1/25, 1/1/26 and 1/1/27."}],"balance_after":7050,"derivative":{"exercise_price":1.47,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":7050},"source":{"system":"sec-edgar","filing":"0001062993-25-000236","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000106299325000236/form4.xml","form_type":"4"}},{"id":1314014,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":84492,"kind":"person","name":"Harris Joseph Michael","position":1,"cik":"0001946070","reported_name":"Harris Joseph Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-03T22:07:23.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":7050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents options granted to the reporting person for his service on the Company's Board of Directors for 2024.  This option vests as to 2,350 shares on each of 1/1/25, 1/1/26 and 1/1/27."}],"balance_after":7050,"derivative":{"exercise_price":1.47,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":7050},"source":{"system":"sec-edgar","filing":"0001062993-25-000235","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000106299325000235/form4.xml","form_type":"4"}},{"id":1314013,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":73210,"kind":"person","name":"Spandow Oliver J.","position":1,"cik":"0001749836","reported_name":"Spandow Oliver J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-03T22:06:44.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":7050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents options granted to the reporting person for his service on the Company's Board of Directors for 2024.  This option vests as to 2,350 shares on each of 1/1/25, 1/1/26 and 1/1/27."}],"balance_after":7050,"derivative":{"exercise_price":1.47,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":7050},"source":{"system":"sec-edgar","filing":"0001062993-25-000233","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000106299325000233/form4.xml","form_type":"4"}},{"id":1314012,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":73210,"kind":"person","name":"Spandow Oliver J.","position":1,"cik":"0001749836","reported_name":"Spandow Oliver J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-03T22:06:44.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":33241,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":114845,"source":{"system":"sec-edgar","filing":"0001062993-25-000233","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000106299325000233/form4.xml","form_type":"4"}},{"id":1498120,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":23456,"kind":"person","name":"Amron Arthur H","position":1,"cik":"0001179697","reported_name":"Amron Arthur H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-30T20:35:22.000Z","date":"2024-05-30","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":2.2449,"value":6734.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average price. These shares of common stock were purchased in multiple transactions at prices ranging from $2.237 to $2.27, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."}],"balance_after":103463,"source":{"system":"sec-edgar","filing":"0001062993-24-011498","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1179697/000106299324011498/form4.xml","form_type":"4"}},{"id":1498119,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":23456,"kind":"person","name":"Amron Arthur H","position":1,"cik":"0001179697","reported_name":"Amron Arthur H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-30T20:35:22.000Z","date":"2024-05-28","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":2.2207,"value":4441.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a weighted average price. These shares of common stock were purchased in multiple transactions at prices ranging from $2.2138 to $2.2276, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."}],"balance_after":100463,"source":{"system":"sec-edgar","filing":"0001062993-24-011498","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1179697/000106299324011498/form4.xml","form_type":"4"}},{"id":1514001,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":56038,"kind":"person","name":"Banks Robert R. Jr.","position":1,"cik":"0001977237","reported_name":"Banks Robert R. Jr.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-05-16T20:49:44.000Z","date":"2024-05-14","kind":"grant","planned":false,"acquired":true,"shares":10406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options to purchase 2,601 shares vest on 5/14/25 and options to purchase the remaining 7,805 shares vest quarterly in 12 equal amounts commencing on 8/14/25."}],"balance_after":10406,"derivative":{"exercise_price":2.14,"expiration_date":"2034-05-14","underlying":"Common Stock","underlying_shares":10406},"source":{"system":"sec-edgar","filing":"0001062993-24-010486","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000106299324010486/form4.xml","form_type":"4"}},{"id":1514000,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":56038,"kind":"person","name":"Banks Robert R. Jr.","position":1,"cik":"0001977237","reported_name":"Banks Robert R. Jr.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-05-16T20:49:44.000Z","date":"2024-05-16","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":2.241,"value":112050.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.10 to $2.25, inclusive. The reporting person undertakes to provide Nephros Inc., any security holder of Nephros Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the set range set forth in this footnote."}],"balance_after":70000,"source":{"system":"sec-edgar","filing":"0001062993-24-010486","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000106299324010486/form4.xml","form_type":"4"}},{"id":1514606,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":23456,"kind":"person","name":"Amron Arthur H","position":1,"cik":"0001179697","reported_name":"Amron Arthur H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-16T20:29:21.000Z","date":"2024-05-14","kind":"grant","planned":false,"acquired":true,"shares":7323,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents options granted to the reporting person for his service on the Company's Board of Directors for 2023.  This option vests as to 2,441 shares on each of 5/14/24, 5/14/25 and 5/14/26."}],"balance_after":7323,"derivative":{"exercise_price":2.14,"expiration_date":"2034-05-14","underlying":"Common Stock","underlying_shares":7323},"source":{"system":"sec-edgar","filing":"0001062993-24-010460","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1179697/000106299324010460/form4.xml","form_type":"4"}},{"id":1513999,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":58047,"kind":"person","name":"Lask Alisa","position":1,"cik":"0001767593","reported_name":"Lask Alisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-16T20:26:53.000Z","date":"2024-05-14","kind":"grant","planned":false,"acquired":true,"shares":7323,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents options granted to the reporting person for her service on the Company's Board of Directors for 2023.  This option vests as to 2,441 shares on each of 5/14/24, 5/14/25 and 5/14/26."}],"balance_after":7323,"derivative":{"exercise_price":2.14,"expiration_date":"2034-05-14","underlying":"Common Stock","underlying_shares":7323},"source":{"system":"sec-edgar","filing":"0001062993-24-010455","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000106299324010455/form4.xml","form_type":"4"}},{"id":1513998,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":73210,"kind":"person","name":"Spandow Oliver J.","position":1,"cik":"0001749836","reported_name":"Spandow Oliver J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-16T20:25:05.000Z","date":"2024-05-14","kind":"grant","planned":false,"acquired":true,"shares":7323,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents options granted to the reporting person for his service on the Company's Board of Directors for 2023.  This option vests as to 2,441 shares on each of 5/14/24, 5/14/25 and 5/14/26."}],"balance_after":7323,"derivative":{"exercise_price":2.14,"expiration_date":"2034-05-14","underlying":"Common Stock","underlying_shares":7323},"source":{"system":"sec-edgar","filing":"0001062993-24-010453","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000106299324010453/form4.xml","form_type":"4"}},{"id":1513997,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":84492,"kind":"person","name":"Harris Joseph Michael","position":1,"cik":"0001946070","reported_name":"Harris Joseph Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-16T20:23:05.000Z","date":"2024-05-14","kind":"grant","planned":false,"acquired":true,"shares":7323,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents options granted to the reporting person for his service on the Company's Board of Directors for 2023.  This option vests as to 2,441 shares on each of 5/14/24, 5/14/25 and 5/14/26."}],"balance_after":7323,"derivative":{"exercise_price":2.14,"expiration_date":"2034-05-14","underlying":"Common Stock","underlying_shares":7323},"source":{"system":"sec-edgar","filing":"0001062993-24-010451","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000106299324010451/form4.xml","form_type":"4"}},{"id":1577235,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":21373,"kind":"organization","name":"WEXFORD CAPITAL LP","position":1,"cik":"0001048462","reported_name":"WEXFORD CAPITAL LP","relationship":{"ten_percent_owner":true}},{"id":21374,"kind":"organization","name":"Wexford GP LLC","position":2,"cik":"0001472112","reported_name":"Wexford GP LLC","relationship":{"ten_percent_owner":true}},{"id":21375,"kind":"person","name":"DAVIDSON CHARLES E","position":3,"cik":"0001001391","reported_name":"DAVIDSON CHARLES E","relationship":{"ten_percent_owner":true}},{"id":21376,"kind":"person","name":"JACOBS JOSEPH","position":4,"cik":"0001048485","reported_name":"JACOBS JOSEPH","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-03-14T20:43:14.000Z","date":"2024-03-13","kind":"other","planned":false,"acquired":false,"shares":91463,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an in-kind distribution by Wexford Capital LP (\"Wexford Capital\") to Arthur Amron that does not involve (i) a purchase or a sale of securities or (ii) any additional consideration, in connection with his separation from service as an employee of Wexford Capital."}],"balance_after":56060,"source":{"system":"sec-edgar","filing":"0001048462-24-000012","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001391/000104846224000012/form4.xml","form_type":"4"}},{"id":1577028,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":23456,"kind":"person","name":"Amron Arthur H","position":1,"cik":"0001179697","reported_name":"Amron Arthur H","relationship":{"director":true}}],"security":"Common stock","published_at":"2024-03-14T20:28:20.000Z","date":"2024-03-13","kind":"other","planned":false,"acquired":true,"shares":91463,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents an in-kind distribution by Wexford Capital LP (\"Wexford Capital\") to Arthur Amron that does not involve (i) a purchase or a sale of securities or (ii) any additional consideration, in connection with his separation from service as an employee of Wexford Capital."}],"balance_after":98463,"source":{"system":"sec-edgar","filing":"0001048462-24-000011","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1179697/000104846224000011/form4.xml","form_type":"4"}},{"id":1577027,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":23456,"kind":"person","name":"Amron Arthur H","position":1,"cik":"0001179697","reported_name":"Amron Arthur H","relationship":{"director":true}}],"security":"Common stock","published_at":"2024-03-14T20:28:20.000Z","date":"2024-03-12","kind":"purchase","planned":false,"acquired":true,"shares":7000,"price":2.4471,"value":17129.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a weighted average price. These shares of common stock were purchased in multiple transactions at prices ranging from $2.3899 to $2.4857, inclusive.  The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."}],"balance_after":7000,"source":{"system":"sec-edgar","filing":"0001048462-24-000011","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1179697/000104846224000011/form4.xml","form_type":"4"}},{"id":1708962,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":73210,"kind":"person","name":"Spandow Oliver J.","position":1,"cik":"0001749836","reported_name":"Spandow Oliver J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-15T21:48:48.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":14294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock granted to the reporting person in lieu of cash fees payable to the reporting person for his service on the Company's Board of Directors for 2023. These shares of restricted stock vest 6 months following the grant date."}],"balance_after":81604,"source":{"system":"sec-edgar","filing":"0001062993-23-022645","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000106299323022645/form4.xml","form_type":"4"}},{"id":1708961,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":58047,"kind":"person","name":"Lask Alisa","position":1,"cik":"0001767593","reported_name":"Lask Alisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-15T21:48:32.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":9291,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock granted to the reporting person in lieu of cash fees payable to the reporting person for her service on the Company's Board of Directors for 2023. These shares of restricted stock vest 6 months following the grant date."}],"balance_after":48629,"source":{"system":"sec-edgar","filing":"0001062993-23-022644","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000106299323022644/form4.xml","form_type":"4"}},{"id":1708960,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":84492,"kind":"person","name":"Harris Joseph Michael","position":1,"cik":"0001946070","reported_name":"Harris Joseph Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-15T21:48:03.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":9291,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock granted to the reporting person in lieu of cash fees payable to the reporting person for his service on the Company's Board of Directors for 2023. These shares of restricted stock vest 6 months following the grant date."}],"balance_after":17693,"source":{"system":"sec-edgar","filing":"0001062993-23-022643","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000106299323022643/form4.xml","form_type":"4"}},{"id":1709618,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":23456,"kind":"person","name":"Amron Arthur H","position":1,"cik":"0001179697","reported_name":"Amron Arthur H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-15T21:47:47.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":9291,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 13, 2023, the Company granted 9,291 shares of restricted stock of the Company (the \"Restricted Stock\") in lieu of cash fees payable to Mr. Amron in respect of his services as a member of the Board of\nDirectors of the Company for 2023. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the \"2015 Plan\"). At the request of Mr. Amron, the Restricted Stock was granted to Wexford Capital LP. The Restricted Stock vests 6 months following the grant date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"On December 13, 2023, the Company granted 9,291 shares of restricted stock of the Company (the \"Restricted Stock\") in lieu of cash fees payable to Mr. Amron in respect of his services as a member of the Board of\nDirectors of the Company for 2023. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the \"2015 Plan\"). At the request of Mr. Amron, the Restricted Stock was granted to Wexford Capital LP. The Restricted Stock vests 6 months following the grant date."}],"balance_after":9291,"source":{"system":"sec-edgar","filing":"0001062993-23-022642","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1179697/000106299323022642/form4.xml","form_type":"4"}},{"id":1716117,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":56038,"kind":"person","name":"Banks Robert R. Jr.","position":1,"cik":"0001977237","reported_name":"Banks Robert R. Jr.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-12-11T21:17:43.000Z","date":"2023-12-07","kind":"purchase","planned":false,"acquired":true,"shares":18000,"price":2.2026,"value":39646.8,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001062993-23-022326","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000106299323022326/form4.xml","form_type":"4"}},{"id":1749811,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":56056,"kind":"person","name":"Krandel Judy","position":1,"cik":"0001668351","reported_name":"Krandel Judy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-11-03T20:30:14.000Z","date":"2023-11-01","kind":"grant","planned":false,"acquired":true,"shares":122524,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 30,631 shares vest on 11/1/24 and options to purchase the remaining 91,893 shares vest quarterly in 12 equal amounts commencing on 2/1/25."}],"balance_after":122524,"derivative":{"exercise_price":1.71,"expiration_date":"2033-11-01","underlying":"Common Stock","underlying_shares":122524},"source":{"system":"sec-edgar","filing":"0001062993-23-020104","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668351/000106299323020104/form4.xml","form_type":"4"}},{"id":1807109,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":56038,"kind":"person","name":"Banks Robert R. Jr.","position":1,"cik":"0001977237","reported_name":"Banks Robert R. Jr.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-08-15T20:15:37.000Z","date":"2023-08-15","kind":"purchase","planned":false,"acquired":true,"shares":1901,"price":1.6869,"value":3206.7969,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $1.66 to $1.73, inclusive.  The reporting person undertakes to provide Nephros Inc., any security holder of Nephros Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the set range set forth in this footnote."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001062993-23-016523","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000106299323016523/form4.xml","form_type":"4"}},{"id":1807108,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":56038,"kind":"person","name":"Banks Robert R. Jr.","position":1,"cik":"0001977237","reported_name":"Banks Robert R. Jr.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-08-15T20:15:37.000Z","date":"2023-08-14","kind":"purchase","planned":false,"acquired":true,"shares":99,"price":1.5,"value":148.5,"ownership":{"direct":true},"balance_after":99,"source":{"system":"sec-edgar","filing":"0001062993-23-016523","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000106299323016523/form4.xml","form_type":"4"}},{"id":2058627,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":58047,"kind":"person","name":"Lask Alisa","position":1,"cik":"0001767593","reported_name":"Lask Alisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-09T21:33:11.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":7080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents options granted to the reporting person for her service on the Company's Board of Directors for 2022. This option vests as to 2,360 shares on each of 1/5/23, 1/5/24 and 1/5/25."}],"balance_after":7080,"derivative":{"exercise_price":1.07,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":7080},"source":{"system":"sec-edgar","filing":"0001062993-23-000721","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000106299323000721/form4.xml","form_type":"4"}},{"id":2058626,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":58047,"kind":"person","name":"Lask Alisa","position":1,"cik":"0001767593","reported_name":"Lask Alisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-09T21:33:11.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":27613,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock granted to the reporting person in lieu of cash fees payable to the reporting person for her service on the Company's Board of Directors for 2022. These shares of restricted stock vest 6 months following the grant date."}],"balance_after":39338,"source":{"system":"sec-edgar","filing":"0001062993-23-000721","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000106299323000721/form4.xml","form_type":"4"}},{"id":2058625,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":73210,"kind":"person","name":"Spandow Oliver J.","position":1,"cik":"0001749836","reported_name":"Spandow Oliver J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-09T21:32:36.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":7080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents options granted to the reporting person for his service on the Company's Board of Directors for 2022. This option vests as to 2,360 shares on each of 1/5/23, 1/5/24 and 1/5/25."}],"balance_after":7080,"derivative":{"exercise_price":1.07,"expiration_date":"2032-01-05","underlying":"Common Stock","underlying_shares":7080},"source":{"system":"sec-edgar","filing":"0001062993-23-000720","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000106299323000720/form4.xml","form_type":"4"}},{"id":2058624,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":73210,"kind":"person","name":"Spandow Oliver J.","position":1,"cik":"0001749836","reported_name":"Spandow Oliver J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-09T21:32:36.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":42481,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock granted to the reporting person in lieu of cash fees payable to the reporting person for his service on the Company's Board of Directors for 2022. These shares of restricted stock vest 6 months following the grant date."}],"balance_after":67310,"source":{"system":"sec-edgar","filing":"0001062993-23-000720","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000106299323000720/form4.xml","form_type":"4"}},{"id":2058623,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":120836,"kind":"person","name":"Gwydir Tom","position":1,"cik":"0001775308","reported_name":"Gwydir Tom","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-09T21:31:54.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":7080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents options granted to the reporting person for his service on the Company's Board of Directors for 2022. This option vests as to 2,360 shares on each of 1/5/23, 1/5/24 and 1/5/25."}],"balance_after":7080,"derivative":{"exercise_price":1.07,"expiration_date":"2023-01-05","underlying":"Common Stock","underlying_shares":7080},"source":{"system":"sec-edgar","filing":"0001062993-23-000719","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000106299323000719/form4.xml","form_type":"4"}},{"id":2058622,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":120836,"kind":"person","name":"Gwydir Tom","position":1,"cik":"0001775308","reported_name":"Gwydir Tom","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-09T21:31:54.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":27613,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock granted to the reporting person in lieu of cash fees payable to the reporting person for his service on the Company's Board of Directors for 2022. These shares of restricted stock vest 6 months following the grant date."}],"balance_after":43226,"source":{"system":"sec-edgar","filing":"0001062993-23-000719","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000106299323000719/form4.xml","form_type":"4"}},{"id":2059089,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":23456,"kind":"person","name":"Amron Arthur H","position":1,"cik":"0001179697","reported_name":"Amron Arthur H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-09T21:31:21.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":7080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 5, 2023, the Company granted an option to purchase 7,080 shares of common stock of the Company (the \"Option\") in respect of the service by Mr. Amron as a member of the Board of Directors of the Company for 2022. The Option was granted under the Company's 2015 Equity Incentive Plan (the \"2015 Plan\"). At the request of Mr. Amron, the Option was granted to Wexford Capital LP. The Option vests as to 2,360 shares on each of 1/5/2023, 1/5/2024 and 1/5/2025."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"On January 5, 2023, the Company granted an option to purchase 7,080 shares of common stock of the Company (the \"Option\") in respect of the service by Mr. Amron as a member of the Board of Directors of the Company for 2022. The Option was granted under the Company's 2015 Equity Incentive Plan (the \"2015 Plan\"). At the request of Mr. Amron, the Option was granted to Wexford Capital LP. The Option vests as to 2,360 shares on each of 1/5/2023, 1/5/2024 and 1/5/2025."}],"balance_after":7080,"derivative":{"exercise_price":1.07,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":7080},"source":{"system":"sec-edgar","filing":"0001062993-23-000718","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1179697/000106299323000718/form4.xml","form_type":"4"}},{"id":2059088,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":23456,"kind":"person","name":"Amron Arthur H","position":1,"cik":"0001179697","reported_name":"Amron Arthur H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-09T21:31:21.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":27613,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 5, 2023, the Company granted 27,613 shares of restricted stock of the Company (the \"Restricted Stock\") in lieu of cash fees payable to Mr. Amron in respect of his services as a member of the Board of\nDirectors of the Company for 2022. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the \"2015 Plan\"). At the request of Mr. Amron, the Restricted Stock was granted to Wexford Capital LP. The\nRestricted Stock vests 6 months following the grant date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"On January 5, 2023, the Company granted 27,613 shares of restricted stock of the Company (the \"Restricted Stock\") in lieu of cash fees payable to Mr. Amron in respect of his services as a member of the Board of\nDirectors of the Company for 2022. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the \"2015 Plan\"). At the request of Mr. Amron, the Restricted Stock was granted to Wexford Capital LP. The\nRestricted Stock vests 6 months following the grant date."}],"balance_after":27613,"source":{"system":"sec-edgar","filing":"0001062993-23-000718","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1179697/000106299323000718/form4.xml","form_type":"4"}},{"id":2058621,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":84492,"kind":"person","name":"Harris Joseph Michael","position":1,"cik":"0001946070","reported_name":"Harris Joseph Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-09T21:30:51.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":7080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents options granted to the reporting person for his service on the Company's Board of Directors for 2022. This option vests as to 2,360 shares on each of 1/5/23, 1/5/24 and 1/5/25."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Represents options granted to the reporting person for his service on the Company's Board of Directors for 2022. This option vests as to 2,360 shares on each of 1/5/23, 1/5/24 and 1/5/25."}],"balance_after":7080,"derivative":{"exercise_price":1.07,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":7080},"source":{"system":"sec-edgar","filing":"0001062993-23-000717","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000106299323000717/form4.xml","form_type":"4"}},{"id":2058620,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":84492,"kind":"person","name":"Harris Joseph Michael","position":1,"cik":"0001946070","reported_name":"Harris Joseph Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-09T21:30:51.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":8402,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock granted to the reporting person in lieu of cash fees payable to the reporting person for his service on the Company's Board of Directors for 2022. These shares of restricted stock vest 6 months following the grant date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Represents shares of restricted stock granted to the reporting person in lieu of cash fees payable to the reporting person for his service on the Company's Board of Directors for 2022. These shares of restricted stock vest 6 months following the grant date."}],"balance_after":8402,"source":{"system":"sec-edgar","filing":"0001062993-23-000717","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000106299323000717/form4.xml","form_type":"4"}},{"id":2162976,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":84492,"kind":"person","name":"Harris Joseph Michael","position":1,"cik":"0001946070","reported_name":"Harris Joseph Michael","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2022-09-08T20:55:15.000Z","date":"2022-09-06","kind":"grant","acquired":true,"shares":13115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 6, 2022, the Company granted to Mr. Harris an option to purchase 13,115 shares of common stock of the Company, of which one-third vested immediately upon the grant date, one-third will vest on the first anniversary of the grant date, and the remaining one-third will vest on the second anniversary of the grant date."}],"balance_after":13115,"derivative":{"exercise_price":1.25,"expiration_date":"2032-09-06","underlying":"Common Stock","underlying_shares":13115},"source":{"system":"sec-edgar","filing":"0001437749-22-022068","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000143774922022068/rdgdoc.xml","form_type":"4"}},{"id":2347954,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":true,"officer":true,"officer_title":"President, CEO & CFO"}}],"security":"Warrants (right to buy)","published_at":"2022-03-07T17:44:41.000Z","date":"2022-03-05","kind":"exercise","acquired":false,"shares":14815,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":2.7,"exercise_date":"2017-03-17","expiration_date":"2022-03-17","underlying":"Common Stock","underlying_shares":14815},"source":{"system":"sec-edgar","filing":"0001437749-22-005408","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000143774922005408/rdgdoc.xml","form_type":"4"}},{"id":2347953,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":true,"officer":true,"officer_title":"President, CEO & CFO"}}],"security":"Common Stock","published_at":"2022-03-07T17:44:41.000Z","date":"2022-03-05","kind":"exercise","acquired":true,"shares":14815,"price":2.7,"value":40000.5,"ownership":{"direct":true},"balance_after":92773,"source":{"system":"sec-edgar","filing":"0001437749-22-005408","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000143774922005408/rdgdoc.xml","form_type":"4"}},{"id":2385009,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":130183,"kind":"person","name":"Lobo Wesley S.","position":1,"cik":"0001841597","reported_name":"Lobo Wesley S.","relationship":{"officer":true,"officer_title":"Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2022-02-18T22:03:01.000Z","date":"2022-02-16","kind":"tax_withholding","acquired":false,"shares":6389,"price":4.8,"value":30667.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person has elected to satisfy his tax withholding obligation in connection with the vesting of a prior restricted stock grant by directing the Company to withhold shares otherwise issuable upon vesting of the previously reported grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 15,000 shares of restricted stock for which the risk of forfeiture will lapse as to 5,000 shares on each of 2/16/23, 2/16/24 and 2/16/25."}],"balance_after":35168,"source":{"system":"sec-edgar","filing":"0001437749-22-003841","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000143774922003841/rdgdoc.xml","form_type":"4"}},{"id":2469626,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":58047,"kind":"person","name":"Lask Alisa","position":1,"cik":"0001767593","reported_name":"Lask Alisa","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-12-17T02:17:32.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":7062,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents options granted to the reporting person for her service on the Company's Board of Directors. This option vests as to 2,354 shares on each of 12/14/21, 12/14/22 and 12/14/23."}],"balance_after":7062,"derivative":{"exercise_price":6.82,"expiration_date":"2031-12-14","underlying":"Common Stock","underlying_shares":7062},"source":{"system":"sec-edgar","filing":"0001437749-21-028836","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000143774921028836/rdgdoc.xml","form_type":"4"}},{"id":2469625,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":58047,"kind":"person","name":"Lask Alisa","position":1,"cik":"0001767593","reported_name":"Lask Alisa","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-12-17T02:17:32.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":4582,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock granted to the reporting person in lieu of cash fees payable to the reporting person for her service on the Company's Board of Directors. These shares of restricted stock vest 6 months following the grant date."}],"balance_after":11725,"source":{"system":"sec-edgar","filing":"0001437749-21-028836","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000143774921028836/rdgdoc.xml","form_type":"4"}},{"id":2469624,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":120836,"kind":"person","name":"Gwydir Tom","position":1,"cik":"0001775308","reported_name":"Gwydir Tom","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-12-17T02:17:05.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":7062,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents options granted to the reporting person for his service on the Company's Board of Directors. This option vests as to 2,354 shares on each of 12/14/21, 12/14/22 and 12/14/23."}],"balance_after":7062,"derivative":{"exercise_price":6.82,"expiration_date":"2031-12-14","underlying":"Common Stock","underlying_shares":7062},"source":{"system":"sec-edgar","filing":"0001437749-21-028835","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000143774921028835/rdgdoc.xml","form_type":"4"}},{"id":2469623,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":120836,"kind":"person","name":"Gwydir Tom","position":1,"cik":"0001775308","reported_name":"Gwydir Tom","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-12-17T02:17:05.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":4582,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock granted to the reporting person in lieu of cash fees payable to the reporting person for his service on the Company's Board of Directors. These shares of restricted stock vest 6 months following the grant date."}],"balance_after":15613,"source":{"system":"sec-edgar","filing":"0001437749-21-028835","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000143774921028835/rdgdoc.xml","form_type":"4"}},{"id":2469622,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":73210,"kind":"person","name":"Spandow Oliver J.","position":1,"cik":"0001749836","reported_name":"Spandow Oliver J.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-17T02:16:43.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":7062,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents options granted to the reporting person for his service on the Company's Board of Directors. This option vests as to 2,354 shares on each of 12/14/21, 12/14/22 and 12/14/23."}],"balance_after":7062,"derivative":{"exercise_price":6.82,"expiration_date":"2031-12-14","underlying":"Common Stock","underlying_shares":7062},"source":{"system":"sec-edgar","filing":"0001437749-21-028834","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000143774921028834/rdgdoc.xml","form_type":"4"}},{"id":2469621,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":73210,"kind":"person","name":"Spandow Oliver J.","position":1,"cik":"0001749836","reported_name":"Spandow Oliver J.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-12-17T02:16:43.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":5429,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock granted to the reporting person in lieu of cash fees payable to the reporting person for his service on the Company's Board of Directors. These shares of restricted stock vest 6 months following the grant date."}],"balance_after":24829,"source":{"system":"sec-edgar","filing":"0001437749-21-028834","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000143774921028834/rdgdoc.xml","form_type":"4"}},{"id":2470221,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":23456,"kind":"person","name":"Amron Arthur H","position":1,"cik":"0001179697","reported_name":"Amron Arthur H","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-17T02:16:22.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":7062,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On December 14, 2021, the Company granted an option to purchase 7,062 shares of common stock of the Company (the \"Option\") in respect of the service by Mr. Amron as a member of the Board of Directors of the\nCompany. The Option was granted under the Company's 2015 Equity Incentive Plan (the \"2015 Plan\"). At the request of Mr. Amron, the Option was granted to Wexford Capital LP. The Option vests as to 2,354 shares on each of 12/14/21, 12/14/22 and 12/14/23."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"On December 14, 2021, the Company granted an option to purchase 7,062 shares of common stock of the Company (the \"Option\") in respect of the service by Mr. Amron as a member of the Board of Directors of the\nCompany. The Option was granted under the Company's 2015 Equity Incentive Plan (the \"2015 Plan\"). At the request of Mr. Amron, the Option was granted to Wexford Capital LP. The Option vests as to 2,354 shares on each of 12/14/21, 12/14/22 and 12/14/23."}],"balance_after":7062,"derivative":{"exercise_price":6.82,"expiration_date":"2031-12-14","underlying":"Common Stock","underlying_shares":7062},"source":{"system":"sec-edgar","filing":"0001437749-21-028833","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1179697/000143774921028833/rdgdoc.xml","form_type":"4"}},{"id":2470220,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":23456,"kind":"person","name":"Amron Arthur H","position":1,"cik":"0001179697","reported_name":"Amron Arthur H","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-12-17T02:16:22.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":4582,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 14, 2021, the Company granted 4,582 shares of restricted stock of the Company (the \"Restricted Stock\") in lieu of cash fees payable to Mr. Amron in respect of his services as a member of the Board of\nDirectors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the \"2015 Plan\"). At the request of Mr. Amron, the Restricted Stock was granted to Wexford Capital LP. The\nRestricted Stock vests 6 months following the grant date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"On December 14, 2021, the Company granted 4,582 shares of restricted stock of the Company (the \"Restricted Stock\") in lieu of cash fees payable to Mr. Amron in respect of his services as a member of the Board of\nDirectors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the \"2015 Plan\"). At the request of Mr. Amron, the Restricted Stock was granted to Wexford Capital LP. The\nRestricted Stock vests 6 months following the grant date."}],"balance_after":4582,"source":{"system":"sec-edgar","filing":"0001437749-21-028833","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1179697/000143774921028833/rdgdoc.xml","form_type":"4"}},{"id":2469931,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-12-16T21:16:03.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":38612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On 12/14/21, the Reporting Person was granted an option to purchase 38,612 shares of common stock of the Company. Options to purchase 9,653 shares vest on 12/14/22 and options to purchase 28,959 shares vest quarterly in 12 equal amounts commencing on 3/14/23."}],"balance_after":38612,"derivative":{"exercise_price":6.82,"expiration_date":"2031-12-14","underlying":"Common Stock","underlying_shares":38612},"source":{"system":"sec-edgar","filing":"0001437749-21-028832","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000143774921028832/rdgdoc.xml","form_type":"4"}},{"id":2578834,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":130183,"kind":"person","name":"Lobo Wesley S.","position":1,"cik":"0001841597","reported_name":"Lobo Wesley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-09-03T20:29:07.000Z","date":"2021-09-01","kind":"grant","acquired":true,"shares":57368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options to purchase 14,342 shares vest on 9/1/22 and options to purchase 43,026  shares vest quarterly in 12 equal amounts commencing on 12/1/22."}],"balance_after":57368,"derivative":{"exercise_price":8.47,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":57368},"source":{"system":"sec-edgar","filing":"0000914190-21-000344","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000091419021000344/edgar.xml","form_type":"4"}},{"id":2593412,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":130183,"kind":"person","name":"Lobo Wesley S.","position":1,"cik":"0001841597","reported_name":"Lobo Wesley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2021-08-23T17:01:26.000Z","date":"2021-08-20","kind":"purchase","acquired":true,"shares":1000,"price":7.92,"value":7920.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 20,557 shares of restricted stock for which the risk of forfeiture will lapse on 2/16/22; and (ii) 20,000 shares of restricted stock for which the risk of forfeiture will lapse as to 5,000 shares on each of 2/16/22, 2/16/23, 2/16/24 and 2/16/25."}],"balance_after":41557,"source":{"system":"sec-edgar","filing":"0000914190-21-000286","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000091419021000286/edgar.xml","form_type":"4"}},{"id":2595935,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":120836,"kind":"person","name":"Gwydir Tom","position":1,"cik":"0001775308","reported_name":"Gwydir Tom","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-20T01:04:35.000Z","date":"2021-08-18","kind":"purchase","acquired":true,"shares":5000,"price":7.64,"value":38200.0,"ownership":{"direct":true},"balance_after":11031,"source":{"system":"sec-edgar","filing":"0000914190-21-000284","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000091419021000284/edgar.xml","form_type":"4"}},{"id":2597972,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-08-18T18:08:02.000Z","date":"2021-08-18","kind":"purchase","acquired":true,"shares":2500,"price":7.7733,"value":19433.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.60 to $7.85. The reporting person undertakes to provide the Company, any security holder of the Company. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":77958,"source":{"system":"sec-edgar","filing":"0000914190-21-000282","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419021000282/edgar.xml","form_type":"4"}},{"id":2597971,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-08-18T18:08:02.000Z","date":"2021-08-17","kind":"purchase","acquired":true,"shares":2500,"price":7.6687,"value":19171.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.66 to $7.6699. The reporting person undertakes to provide the Company, any security holder of the Company. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":75458,"source":{"system":"sec-edgar","filing":"0000914190-21-000282","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419021000282/edgar.xml","form_type":"4"}},{"id":2684499,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":21373,"kind":"organization","name":"WEXFORD CAPITAL LP","position":1,"cik":"0001048462","reported_name":"WEXFORD CAPITAL LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21374,"kind":"organization","name":"Wexford GP LLC","position":2,"cik":"0001472112","reported_name":"Wexford GP LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21375,"kind":"person","name":"DAVIDSON CHARLES E","position":3,"cik":"0001001391","reported_name":"DAVIDSON CHARLES E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21376,"kind":"person","name":"JACOBS JOSEPH","position":4,"cik":"0001048485","reported_name":"JACOBS JOSEPH","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock Warrants","published_at":"2021-06-03T20:41:10.000Z","date":"2021-06-01","kind":"other","acquired":false,"shares":66667,"price":2.7,"value":180000.9,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Wexford Capital LP (\"Wexford Capital\") may, by reason of its status as (i) investment manager of WP11, (ii) manager of WPIC2 and (iii) sub-advisor of WST, be deemed to own beneficially the securities held by the Wexford Entities and WST. Wexford GP LLC (\"Wexford GP\") may, as the General Partner of Wexford Capital, be deemed to own beneficially the securities held by the Wexford Entities and WST. Each of Charles E. Davidson (\"Davidson\") and Joseph M. Jacobs (\"Jacobs\", and together with Wexford Capital, Wexford GP and Davidson, the \"Reporting Persons\") may, by reason of his status as a controlling person of Wexford GP and Wexford Advisors, be deemed to own beneficially the securities held by the Wexford Entities, Wexford Advisors and WST."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Wexford Capital, Wexford GP, Davidson and Jacobs share the power to vote and to dispose of the securities beneficially owned by the Wexford Entities and WST. Each of Davidson and Jacobs share the power to vote and to dispose of the securities beneficially owned by Wexford Advisors. Each of Wexford Capital, Wexford GP, Davidson and Jacobs disclaim beneficial ownership of the securities owned by the Wexford Entities, Wexford Advisors and/or WST, as applicable, and this report shall not be deemed as an admission that they are the beneficial owners of such securities, except to the extent of any pecuniary interests therein. The Reporting Persons may be deemed to be directors by deputization by virtue of Arthur Amron, an employee of Wexford Capital, serving as a director of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":2.7,"exercise_date":"2016-06-03","expiration_date":"2021-06-03","underlying":"Common Stock","underlying_shares":66667},"source":{"system":"sec-edgar","filing":"0000902664-21-002989","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001391/000090266421002989/ownership.xml","form_type":"4"}},{"id":2684498,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":21373,"kind":"organization","name":"WEXFORD CAPITAL LP","position":1,"cik":"0001048462","reported_name":"WEXFORD CAPITAL LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21374,"kind":"organization","name":"Wexford GP LLC","position":2,"cik":"0001472112","reported_name":"Wexford GP LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21375,"kind":"person","name":"DAVIDSON CHARLES E","position":3,"cik":"0001001391","reported_name":"DAVIDSON CHARLES E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21376,"kind":"person","name":"JACOBS JOSEPH","position":4,"cik":"0001048485","reported_name":"JACOBS JOSEPH","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-03T20:41:10.000Z","date":"2021-06-01","kind":"other","acquired":true,"shares":66667,"price":2.7,"value":180000.9,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the common stock of the Issuer acquired in connection with the exercise of 66,667 common stock warrants held in the aggregate by Wexford Partners 11, L.P., (\"WP11\"), WPIC 2 LLC (\"WPIC2\", and together with WP11, the \"Wexford Entities\") and Wexford 11 Advisors LLC (\"WP Advisors\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents the common stock of the Issuer held in the aggregate by the Wexford Entities, WP Advisors and Wexford Spectrum Trading Limited (\"WST\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Wexford Capital LP (\"Wexford Capital\") may, by reason of its status as (i) investment manager of WP11, (ii) manager of WPIC2 and (iii) sub-advisor of WST, be deemed to own beneficially the securities held by the Wexford Entities and WST. Wexford GP LLC (\"Wexford GP\") may, as the General Partner of Wexford Capital, be deemed to own beneficially the securities held by the Wexford Entities and WST. Each of Charles E. Davidson (\"Davidson\") and Joseph M. Jacobs (\"Jacobs\", and together with Wexford Capital, Wexford GP and Davidson, the \"Reporting Persons\") may, by reason of his status as a controlling person of Wexford GP and Wexford Advisors, be deemed to own beneficially the securities held by the Wexford Entities, Wexford Advisors and WST."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Wexford Capital, Wexford GP, Davidson and Jacobs share the power to vote and to dispose of the securities beneficially owned by the Wexford Entities and WST. Each of Davidson and Jacobs share the power to vote and to dispose of the securities beneficially owned by Wexford Advisors. Each of Wexford Capital, Wexford GP, Davidson and Jacobs disclaim beneficial ownership of the securities owned by the Wexford Entities, Wexford Advisors and/or WST, as applicable, and this report shall not be deemed as an admission that they are the beneficial owners of such securities, except to the extent of any pecuniary interests therein. The Reporting Persons may be deemed to be directors by deputization by virtue of Arthur Amron, an employee of Wexford Capital, serving as a director of the Issuer."}],"balance_after":3544492,"source":{"system":"sec-edgar","filing":"0000902664-21-002989","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001391/000090266421002989/ownership.xml","form_type":"4"}},{"id":2688779,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO Specialty Renal Products"}}],"security":"Common Stock","published_at":"2021-06-01T21:39:58.000Z","date":"2021-05-27","kind":"tax_withholding","acquired":false,"shares":349,"price":2.7,"value":942.3,"ownership":{"direct":false,"nature":"By UTMA #2"},"balance_after":8669,"source":{"system":"sec-edgar","filing":"0000914190-21-000169","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419021000169/edgar.xml","form_type":"4/A","original_submission_date":"2021-05-25"}},{"id":2688778,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO Specialty Renal Products"}}],"security":"Common Stock","published_at":"2021-06-01T21:39:58.000Z","date":"2021-05-27","kind":"tax_withholding","acquired":false,"shares":349,"price":2.7,"value":942.3,"ownership":{"direct":false,"nature":"By UTMA #1"},"balance_after":8947,"source":{"system":"sec-edgar","filing":"0000914190-21-000169","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419021000169/edgar.xml","form_type":"4/A","original_submission_date":"2021-05-25"}},{"id":2696812,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO of Specialty Renal Product"}}],"security":"Common Stock Warrants (Right to Buy)","published_at":"2021-05-25T19:40:39.000Z","date":"2021-05-24","kind":"other","acquired":false,"shares":1111,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By UTMA #2"},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"Previous filings mistakenly reflected this amount as 1,112 shares; the correct amount after appropriate rounding adjustments is 1,111 shares, as reflected above."}],"balance_after":0,"derivative":{"exercise_price":2.7,"exercise_date":"2016-06-03","expiration_date":"2021-06-03","underlying":"Common Stock","underlying_shares":1111},"source":{"system":"sec-edgar","filing":"0000914190-21-000162","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419021000162/edgar.xml","form_type":"4"}},{"id":2696811,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO of Specialty Renal Product"}}],"security":"Common Stock Warrants (Right to Buy)","published_at":"2021-05-25T19:40:39.000Z","date":"2021-05-24","kind":"other","acquired":false,"shares":1111,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By UTMA #1"},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"Previous filings mistakenly reflected this amount as 1,112 shares; the correct amount after appropriate rounding adjustments is 1,111 shares, as reflected above."}],"balance_after":0,"derivative":{"exercise_price":2.7,"exercise_date":"2016-06-03","expiration_date":"2021-06-03","underlying":"Common Stock","underlying_shares":1111},"source":{"system":"sec-edgar","filing":"0000914190-21-000162","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419021000162/edgar.xml","form_type":"4"}},{"id":2696810,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO of Specialty Renal Product"}}],"security":"Common Stock","published_at":"2021-05-25T19:40:39.000Z","date":"2021-05-24","kind":"other","acquired":true,"shares":1111,"price":2.7,"value":2999.7,"ownership":{"direct":false,"nature":"By UTMA #2"},"balance_after":9018,"source":{"system":"sec-edgar","filing":"0000914190-21-000162","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419021000162/edgar.xml","form_type":"4"}},{"id":2696809,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO of Specialty Renal Product"}}],"security":"Common Stock","published_at":"2021-05-25T19:40:39.000Z","date":"2021-05-24","kind":"other","acquired":true,"shares":1111,"price":2.7,"value":2999.7,"ownership":{"direct":false,"nature":"By UTMA #1"},"balance_after":9296,"source":{"system":"sec-edgar","filing":"0000914190-21-000162","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419021000162/edgar.xml","form_type":"4"}},{"id":2849347,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":130183,"kind":"person","name":"Lobo Wesley S.","position":1,"cik":"0001841597","reported_name":"Lobo Wesley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Marketing Officer"}}],"security":"Stock Optoin (right to buy)","published_at":"2021-02-18T22:48:46.000Z","date":"2021-02-16","kind":"grant","acquired":true,"shares":114178,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to purchase 28,545 shares vest on 2/16/22 and options to purchase 85,633 shares vest quarterly in 12 equal amounts commencing on 5/16/22."}],"balance_after":114178,"derivative":{"exercise_price":8.66,"expiration_date":"2031-02-16","underlying":"Common Stock","underlying_shares":114178},"source":{"system":"sec-edgar","filing":"0000914190-21-000070","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000091419021000070/edgar.xml","form_type":"4"}},{"id":2849346,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":130183,"kind":"person","name":"Lobo Wesley S.","position":1,"cik":"0001841597","reported_name":"Lobo Wesley S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2021-02-18T22:48:46.000Z","date":"2021-02-16","kind":"grant","acquired":true,"shares":40557,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes (i) 20,557 shares of restricted stock for which the risk of forfeiture will lapse on 2/16/22; and (ii) 20,000 shares of restricted stock for which the risk of forfeiture will lapse as to 5,000 shares on each of 2/16/22, 2/16/23, 2/16/24 and 2/16/25."}],"balance_after":40557,"source":{"system":"sec-edgar","filing":"0000914190-21-000070","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000091419021000070/edgar.xml","form_type":"4"}},{"id":2891017,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":21373,"kind":"organization","name":"WEXFORD CAPITAL LP","position":1,"cik":"0001048462","reported_name":"WEXFORD CAPITAL LP","relationship":{"director":true,"ten_percent_owner":true}},{"id":21374,"kind":"organization","name":"Wexford GP LLC","position":2,"cik":"0001472112","reported_name":"Wexford GP LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":21375,"kind":"person","name":"DAVIDSON CHARLES E","position":3,"cik":"0001001391","reported_name":"DAVIDSON CHARLES E","relationship":{"director":true,"ten_percent_owner":true}},{"id":21376,"kind":"person","name":"JACOBS JOSEPH","position":4,"cik":"0001048485","reported_name":"JACOBS JOSEPH","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-29T21:49:53.000Z","date":"2021-01-27","kind":"exercise","acquired":false,"shares":4477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes the options reported in the Form 4 filed by Arthur Amron on December 22, 2017."}],"balance_after":4477,"derivative":{"exercise_price":4.5,"exercise_date":"2019-12-20","expiration_date":"2021-01-29","underlying":"Common Stock","underlying_shares":4477},"source":{"system":"sec-edgar","filing":"0001048462-21-000005","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1001391/000104846221000005/form4.xml","form_type":"4"}},{"id":2891016,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":21373,"kind":"organization","name":"WEXFORD CAPITAL LP","position":1,"cik":"0001048462","reported_name":"WEXFORD CAPITAL LP","relationship":{"director":true,"ten_percent_owner":true}},{"id":21374,"kind":"organization","name":"Wexford GP LLC","position":2,"cik":"0001472112","reported_name":"Wexford GP LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":21375,"kind":"person","name":"DAVIDSON CHARLES E","position":3,"cik":"0001001391","reported_name":"DAVIDSON CHARLES E","relationship":{"director":true,"ten_percent_owner":true}},{"id":21376,"kind":"person","name":"JACOBS JOSEPH","position":4,"cik":"0001048485","reported_name":"JACOBS JOSEPH","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-29T21:49:53.000Z","date":"2021-01-27","kind":"exercise","acquired":false,"shares":3765,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes the options reported in the Form 4 filed by Arthur Amron on August 25, 2016."}],"balance_after":3765,"derivative":{"exercise_price":3.6,"exercise_date":"2018-08-24","expiration_date":"2021-01-29","underlying":"Common Stock","underlying_shares":3765},"source":{"system":"sec-edgar","filing":"0001048462-21-000005","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1001391/000104846221000005/form4.xml","form_type":"4"}},{"id":2891015,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":21373,"kind":"organization","name":"WEXFORD CAPITAL LP","position":1,"cik":"0001048462","reported_name":"WEXFORD CAPITAL LP","relationship":{"director":true,"ten_percent_owner":true}},{"id":21374,"kind":"organization","name":"Wexford GP LLC","position":2,"cik":"0001472112","reported_name":"Wexford GP LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":21375,"kind":"person","name":"DAVIDSON CHARLES E","position":3,"cik":"0001001391","reported_name":"DAVIDSON CHARLES E","relationship":{"director":true,"ten_percent_owner":true}},{"id":21376,"kind":"person","name":"JACOBS JOSEPH","position":4,"cik":"0001048485","reported_name":"JACOBS JOSEPH","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-29T21:49:53.000Z","date":"2021-01-27","kind":"exercise","acquired":false,"shares":2956,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes the options reported in the Form 4 filed by Arthur Amron on March 27, 2014."}],"balance_after":2956,"derivative":{"exercise_price":4.14,"exercise_date":"2016-03-26","expiration_date":"2021-01-29","underlying":"Common Stock","underlying_shares":2956},"source":{"system":"sec-edgar","filing":"0001048462-21-000005","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1001391/000104846221000005/form4.xml","form_type":"4"}},{"id":2891014,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":21373,"kind":"organization","name":"WEXFORD CAPITAL LP","position":1,"cik":"0001048462","reported_name":"WEXFORD CAPITAL LP","relationship":{"director":true,"ten_percent_owner":true}},{"id":21374,"kind":"organization","name":"Wexford GP LLC","position":2,"cik":"0001472112","reported_name":"Wexford GP LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":21375,"kind":"person","name":"DAVIDSON CHARLES E","position":3,"cik":"0001001391","reported_name":"DAVIDSON CHARLES E","relationship":{"director":true,"ten_percent_owner":true}},{"id":21376,"kind":"person","name":"JACOBS JOSEPH","position":4,"cik":"0001048485","reported_name":"JACOBS JOSEPH","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-29T21:49:53.000Z","date":"2021-01-27","kind":"exercise","acquired":false,"shares":3556,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes the options reported in the Form 4 filed by Arthur Amron on March 28, 2011."}],"balance_after":3556,"derivative":{"exercise_price":4.59,"exercise_date":"2014-03-24","expiration_date":"2021-01-29","underlying":"Common Stock","underlying_shares":3556},"source":{"system":"sec-edgar","filing":"0001048462-21-000005","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1001391/000104846221000005/form4.xml","form_type":"4"}},{"id":2891013,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":21373,"kind":"organization","name":"WEXFORD CAPITAL LP","position":1,"cik":"0001048462","reported_name":"WEXFORD CAPITAL LP","relationship":{"director":true,"ten_percent_owner":true}},{"id":21374,"kind":"organization","name":"Wexford GP LLC","position":2,"cik":"0001472112","reported_name":"Wexford GP LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":21375,"kind":"person","name":"DAVIDSON CHARLES E","position":3,"cik":"0001001391","reported_name":"DAVIDSON CHARLES E","relationship":{"director":true,"ten_percent_owner":true}},{"id":21376,"kind":"person","name":"JACOBS JOSEPH","position":4,"cik":"0001048485","reported_name":"JACOBS JOSEPH","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2021-01-29T21:49:53.000Z","date":"2021-01-27","kind":"exercise","acquired":true,"shares":4477,"price":4.5,"value":20146.5,"ownership":{"direct":true},"balance_after":106037,"source":{"system":"sec-edgar","filing":"0001048462-21-000005","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1001391/000104846221000005/form4.xml","form_type":"4"}},{"id":2891012,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":21373,"kind":"organization","name":"WEXFORD CAPITAL LP","position":1,"cik":"0001048462","reported_name":"WEXFORD CAPITAL LP","relationship":{"director":true,"ten_percent_owner":true}},{"id":21374,"kind":"organization","name":"Wexford GP LLC","position":2,"cik":"0001472112","reported_name":"Wexford GP LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":21375,"kind":"person","name":"DAVIDSON CHARLES E","position":3,"cik":"0001001391","reported_name":"DAVIDSON CHARLES E","relationship":{"director":true,"ten_percent_owner":true}},{"id":21376,"kind":"person","name":"JACOBS JOSEPH","position":4,"cik":"0001048485","reported_name":"JACOBS JOSEPH","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2021-01-29T21:49:53.000Z","date":"2021-01-27","kind":"exercise","acquired":true,"shares":3765,"price":3.6,"value":13554.0,"ownership":{"direct":true},"balance_after":101560,"source":{"system":"sec-edgar","filing":"0001048462-21-000005","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001391/000104846221000005/form4.xml","form_type":"4"}},{"id":2891011,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":21373,"kind":"organization","name":"WEXFORD CAPITAL LP","position":1,"cik":"0001048462","reported_name":"WEXFORD CAPITAL LP","relationship":{"director":true,"ten_percent_owner":true}},{"id":21374,"kind":"organization","name":"Wexford GP LLC","position":2,"cik":"0001472112","reported_name":"Wexford GP LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":21375,"kind":"person","name":"DAVIDSON CHARLES E","position":3,"cik":"0001001391","reported_name":"DAVIDSON CHARLES E","relationship":{"director":true,"ten_percent_owner":true}},{"id":21376,"kind":"person","name":"JACOBS JOSEPH","position":4,"cik":"0001048485","reported_name":"JACOBS JOSEPH","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2021-01-29T21:49:53.000Z","date":"2021-01-27","kind":"exercise","acquired":true,"shares":2956,"price":4.14,"value":12237.84,"ownership":{"direct":true},"balance_after":97795,"source":{"system":"sec-edgar","filing":"0001048462-21-000005","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001391/000104846221000005/form4.xml","form_type":"4"}},{"id":2891010,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":21373,"kind":"organization","name":"WEXFORD CAPITAL LP","position":1,"cik":"0001048462","reported_name":"WEXFORD CAPITAL LP","relationship":{"director":true,"ten_percent_owner":true}},{"id":21374,"kind":"organization","name":"Wexford GP LLC","position":2,"cik":"0001472112","reported_name":"Wexford GP LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":21375,"kind":"person","name":"DAVIDSON CHARLES E","position":3,"cik":"0001001391","reported_name":"DAVIDSON CHARLES E","relationship":{"director":true,"ten_percent_owner":true}},{"id":21376,"kind":"person","name":"JACOBS JOSEPH","position":4,"cik":"0001048485","reported_name":"JACOBS JOSEPH","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2021-01-29T21:49:53.000Z","date":"2021-01-27","kind":"exercise","acquired":true,"shares":3556,"price":4.59,"value":16322.04,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes vested and unvested shares of common stock granted to Wexford Capital LP (\"Wexford Capital\") as reported in Form 4s previously filed by Arthur Amron and Paul Mieyal, respectively, a current and former director of the Company and a current and former employee of Wexford Capital."}],"balance_after":94839,"source":{"system":"sec-edgar","filing":"0001048462-21-000005","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001391/000104846221000005/form4.xml","form_type":"4"}},{"id":2912804,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":21373,"kind":"organization","name":"WEXFORD CAPITAL LP","position":1,"cik":"0001048462","reported_name":"WEXFORD CAPITAL LP","relationship":{"director":true,"ten_percent_owner":true}},{"id":21374,"kind":"organization","name":"Wexford GP LLC","position":2,"cik":"0001472112","reported_name":"Wexford GP LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":21375,"kind":"person","name":"DAVIDSON CHARLES E","position":3,"cik":"0001001391","reported_name":"DAVIDSON CHARLES E","relationship":{"director":true,"ten_percent_owner":true}},{"id":21376,"kind":"person","name":"JACOBS JOSEPH","position":4,"cik":"0001048485","reported_name":"JACOBS JOSEPH","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2021-01-08T22:41:09.000Z","date":"2021-01-06","kind":"grant","acquired":true,"shares":3196,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 6, 2021, the Company granted 3,196 shares of restricted stock of the Company (the \"Restricted Stock\") in lieu of cash fees payable to Mr. Paul Mieyal in respect of his services as a member of the Board of Directors of the Company through October 28, 2020. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the \"2015 Plan\"). At the request of Mr. Mieyal, the Restricted Stock was granted to Wexford Capital LP. The Restricted Stock vests 6 months following the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On January 6, 2021, the Company granted 3,196 shares of restricted stock of the Company (the \"Restricted Stock\") in lieu of cash fees payable to Mr. Paul Mieyal in respect of his services as a member of the Board of Directors of the Company through October 28, 2020. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the \"2015 Plan\"). At the request of Mr. Mieyal, the Restricted Stock was granted to Wexford Capital LP. The Restricted Stock vests 6 months following the grant date."}],"balance_after":3196,"source":{"system":"sec-edgar","filing":"0001048462-21-000003","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001391/000104846221000003/form4.xml","form_type":"4"}},{"id":2912041,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":120836,"kind":"person","name":"Gwydir Tom","position":1,"cik":"0001775308","reported_name":"Gwydir Tom","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-01-08T22:32:26.000Z","date":"2021-01-06","kind":"grant","acquired":true,"shares":6850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents options granted to the reporting person for his service on the Company's Board of Directors. This option vests as to 2,284 shares on 1/6/21 and as to 2,283 shares on each of 1/6/22 and 1/6/23."}],"balance_after":6850,"derivative":{"exercise_price":8.06,"expiration_date":"2031-01-06","underlying":"Common Stock","underlying_shares":6850},"source":{"system":"sec-edgar","filing":"0000914190-21-000010","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000091419021000010/edgar.xml","form_type":"4"}},{"id":2912040,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":120836,"kind":"person","name":"Gwydir Tom","position":1,"cik":"0001775308","reported_name":"Gwydir Tom","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-08T22:32:26.000Z","date":"2021-01-06","kind":"grant","acquired":true,"shares":3666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock granted to the reporting person in lieu of cash fees payable to the reporting person for his service on the Company's Board of Directors. These shares of restricted stock vest 6 months following the grant date."}],"balance_after":6031,"source":{"system":"sec-edgar","filing":"0000914190-21-000010","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000091419021000010/edgar.xml","form_type":"4"}},{"id":2912039,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":58047,"kind":"person","name":"Lask Alisa","position":1,"cik":"0001767593","reported_name":"Lask Alisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-01-08T22:31:58.000Z","date":"2021-01-06","kind":"grant","acquired":true,"shares":6850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents options granted to the reporting person for her service on the Company's Board of Directors. This option vests as to 2,284 shares on 1/6/21 and as to 2,283 shares on each of 1/6/22 and 1/6/23."}],"balance_after":6850,"derivative":{"exercise_price":8.06,"expiration_date":"2031-01-06","underlying":"Common Stock","underlying_shares":6850},"source":{"system":"sec-edgar","filing":"0000914190-21-000009","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000091419021000009/edgar.xml","form_type":"4"}},{"id":2912038,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":58047,"kind":"person","name":"Lask Alisa","position":1,"cik":"0001767593","reported_name":"Lask Alisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-08T22:31:58.000Z","date":"2021-01-06","kind":"grant","acquired":true,"shares":3666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock granted to the reporting person in lieu of cash fees payable to the reporting person for her service on the Company's Board of Directors. These shares of restricted stock vest 6 months following the grant date."}],"balance_after":7143,"source":{"system":"sec-edgar","filing":"0000914190-21-000009","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000091419021000009/edgar.xml","form_type":"4"}},{"id":2912037,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":73210,"kind":"person","name":"Spandow Oliver J.","position":1,"cik":"0001749836","reported_name":"Spandow Oliver J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-08T22:31:02.000Z","date":"2021-01-06","kind":"grant","acquired":true,"shares":6850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents options granted to the reporting person for his service on the Company's Board of Directors. This option vests as to 2,284 shares on 1/6/21 and as to 2,283 shares on each of 1/6/22 and 1/6/23."}],"balance_after":6850,"derivative":{"exercise_price":8.06,"expiration_date":"2031-01-06","underlying":"Common Stock","underlying_shares":6850},"source":{"system":"sec-edgar","filing":"0000914190-21-000007","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000091419021000007/edgar.xml","form_type":"4"}},{"id":2912036,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":73210,"kind":"person","name":"Spandow Oliver J.","position":1,"cik":"0001749836","reported_name":"Spandow Oliver J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-08T22:31:02.000Z","date":"2021-01-06","kind":"grant","acquired":true,"shares":3666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock granted to the reporting person in lieu of cash fees payable to the reporting person for his service on the Company's Board of Directors. These shares of restricted stock vest 6 months following the grant date."}],"balance_after":19400,"source":{"system":"sec-edgar","filing":"0000914190-21-000007","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196298/000091419021000007/edgar.xml","form_type":"4"}},{"id":2912430,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":23456,"kind":"person","name":"Amron Arthur H","position":1,"cik":"0001179697","reported_name":"AMRON ARTHUR H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-08T22:30:36.000Z","date":"2021-01-06","kind":"grant","acquired":true,"shares":6850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 6, 2021, the Company granted an option to purchase 6,850 shares of common stock of the Company (the \"Option\") in respect of the service by Mr. Amron as a member of the Board of Directors of the Company. The Option was granted under the Company's 2015 Equity Incentive Plan (the \"2015 Plan\"). At the request of Mr. Amron, the Option was granted to Wexford Capital LP. The Option vests as to 2,284 shares on 1/6/21, and as to 2,283 shares on 1/6/22 and 1/6/23."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"On January 6, 2021, the Company granted an option to purchase 6,850 shares of common stock of the Company (the \"Option\") in respect of the service by Mr. Amron as a member of the Board of Directors of the Company. The Option was granted under the Company's 2015 Equity Incentive Plan (the \"2015 Plan\"). At the request of Mr. Amron, the Option was granted to Wexford Capital LP. The Option vests as to 2,284 shares on 1/6/21, and as to 2,283 shares on 1/6/22 and 1/6/23."}],"balance_after":6850,"derivative":{"exercise_price":8.06,"expiration_date":"2031-01-06","underlying":"Common Stock","underlying_shares":6850},"source":{"system":"sec-edgar","filing":"0000914190-21-000006","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1179697/000091419021000006/edgar.xml","form_type":"4"}},{"id":2912429,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":23456,"kind":"person","name":"Amron Arthur H","position":1,"cik":"0001179697","reported_name":"AMRON ARTHUR H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-08T22:30:36.000Z","date":"2021-01-06","kind":"grant","acquired":true,"shares":3666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 6, 2021, the Company granted 3,666 shares of restricted stock of the Company (the \"Restricted Stock\") in lieu of cash fees payable to Mr. Amron in respect of his services as a member of the Board of Directors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the \"2015 Plan\"). At the request of Mr. Amron, the Restricted Stock was granted to Wexford Capital LP. The Restricted Stock vests 6 months following the grant date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"On January 6, 2021, the Company granted 3,666 shares of restricted stock of the Company (the \"Restricted Stock\") in lieu of cash fees payable to Mr. Amron in respect of his services as a member of the Board of Directors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the \"2015 Plan\"). At the request of Mr. Amron, the Restricted Stock was granted to Wexford Capital LP. The Restricted Stock vests 6 months following the grant date."}],"balance_after":3666,"source":{"system":"sec-edgar","filing":"0000914190-21-000006","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1179697/000091419021000006/edgar.xml","form_type":"4"}}],"next_cursor":"2021-01-08T22:30:36.000000Z,2912429"}